Skip to content

Improving Cognitive Impairment in Cancer Patients With an Online Course in Mindfulness-Based Stress Reduction-A Randomized Controlled Trial.

Anna Baumeister, Lea Schuurmans, Lisa Borgmann, Alena Krause, Luca Schmidt, Steffen Moritz, Matthias Rostock

Psycho-Oncology August 2026 DOI: 10.1002/pon.70566 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 170
Population Cancer patients with cognitive impairments, 3 months to 5 years after completing antitumor therapy
Duration 8-week intervention, 3-month follow-up
Measures FACT-Cog, FACT-G, BFI, PHQ-9, Go-No-Go, VLMT
Topics Meditation
Keywords Online course Psycho‐oncology
Key findings Online MBSR significantly improved subjective neurocognitive functioning (FACT-Cog, Cohen's d = 0.36-0.72), quality of life (FACT-G, d = 0.32), fatigue (BFI, d = -0.47), depressive symptoms (PHQ-9, d = -0.57), and objective memory (VLMT, d = 0.25) compared to waitlist, with effects maintained at 3-month follow-up.

Abstract

Cancer patients often suffer from neurocognitive impairments due to cancer treatment, the cancer itself, and/or coping with the illness, significantly impairing quality of life and everyday functioning. This study evaluates the effectiveness of an online MBSR course regarding neurocognitive functioning and well-being of cancer patients. A total of 170 cancer patients with cognitive impairments 3 months to 5 years after completing antitumor therapy were randomized to an online MBSR course led by an experienced therapist or a waitlist control group. Assessments were conducted online at baseline (T0) and post-intervention (T1, 8 weeks). The control group then received the intervention and was assessed again after 8 weeks (T2). Both groups completed a 3-month follow-up (T3). The primary outcome was subjective neurocognitive functioning (FACT-Cog). Secondary outcomes included quality of life (FACT-G), fatigue (BFI), depressive symptoms (PHQ-9), attention (Go-No-Go), and verbal learning and memory (VLMT). Outcomes were analyzed using mixed models for repeated measures. Subjective neurocognitive functioning (FACT-Cog) improved significantly in the intervention group compared to controls at T1 (Cohen's d = 0.36-0.72, p = 0.004-< 0.001, depending on subscale), as well as quality of life (FACT-G, Cohen's d = 0.32, p = 0.001), fatigue (BFI, Cohen's d = -0.47, p < 0.001), and depressive symptoms (PHQ-9, Cohen's d = -0.57, p < 0.001). Objective memory performance (VLMT, Cohen's d = 0.25, p = 0.030) improved. Effects were maintained at 3-month follow-up. The online MBSR course can effectively improve cancer-related cognitive impairment and well-being of cancer patients.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics